Shanghai Model Organisms Center, Inc. (688265.SS)
CNY 24.61
(-2.3%)
CNY 24.61
(-2.3%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 40.71 Million CNY | 2.81% |
| 2022 | 40.26 Million CNY | -61.69% |
| 2021 | 96.25 Million CNY | 53.78% |
| 2020 | 62.88 Million CNY | 85.57% |
| 2019 | 38.51 Million CNY | 113.6% |
| 2018 | 27.56 Million CNY | 241.83% |
| 2017 | -12.43 Million CNY | -169.33% |
| 2016 | 14.98 Million CNY | 41.77% |
| 2015 | 10.56 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -13.88 Million CNY | -262.38% |
| 2024 Q2 | 316.06 Thousand CNY | 112.42% |
| 2024 Q3 | -6.8 Million CNY | -494.6% |
| 2023 Q4 | -3.55 Million CNY | 59.57% |
| 2023 Q1 | -7.53 Million CNY | -45.39% |
| 2023 Q3 | -8.79 Million CNY | -228.68% |
| 2023 Q2 | 6.83 Million CNY | 190.69% |
| 2023 FY | - CNY | 2.81% |
| 2022 Q1 | 9.52 Million CNY | -69.35% |
| 2022 FY | - CNY | -61.69% |
| 2022 Q4 | -5.18 Million CNY | -206.65% |
| 2022 Q3 | 4.86 Million CNY | 222.98% |
| 2022 Q2 | -3.95 Million CNY | -141.49% |
| 2021 FY | - CNY | 53.78% |
| 2021 Q1 | 54.3 Million CNY | 137.45% |
| 2021 Q2 | -23.59 Million CNY | -143.45% |
| 2021 Q3 | 19.59 Million CNY | 183.03% |
| 2021 Q4 | 31.08 Million CNY | 58.64% |
| 2020 Q3 | 15.64 Million CNY | 123.03% |
| 2020 Q1 | 7.01 Million CNY | 0.0% |
| 2020 Q4 | 22.86 Million CNY | 46.21% |
| 2020 FY | - CNY | 85.57% |
| 2020 Q2 | 7.01 Million CNY | 0.0% |
| 2019 FY | - CNY | 113.6% |
| 2018 Q2 | 10.58 Million CNY | 0.0% |
| 2018 FY | - CNY | 241.83% |
| 2018 Q1 | 10.58 Million CNY | 80.18% |
| 2017 Q1 | 6.22 Million CNY | 23.97% |
| 2017 Q2 | 6.22 Million CNY | -0.0% |
| 2017 Q3 | 5.87 Million CNY | -5.65% |
| 2017 Q4 | 5.87 Million CNY | 0.0% |
| 2017 FY | - CNY | -169.33% |
| 2016 FY | - CNY | 41.77% |
| 2016 Q4 | 5.02 Million CNY | 0.0% |
| 2016 Q3 | 5.02 Million CNY | 103.27% |
| 2016 Q2 | 2.47 Million CNY | -0.0% |
| 2016 Q1 | 2.47 Million CNY | 0.0% |
| 2015 FY | - CNY | 0.0% |